23andMe CEO Anne Wojcicki opens up about the high-stakes decision to buy back the DNA-testing giant with her own capital. On The Circuit, she tells @EmilyChangTV why she wanted to turn the company into a science platform for global health discoveries https://t.co/KwLnBvvCky https://t.co/eIOaPR5qZa